-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemia: Clinical Studies: Poster II

Acute Myeloid Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Varun C Dhulipala, MD1,2, Martine Extermann, MD, PhD3,4, Najla Al Ali1*, Jongphil Kim2,5*, Marina Sehovic, MD, MPH1*, Tea Reljic2*, Benjamin Djulbegovic, MD, PhD1,2 and Jeffrey E Lancet, MD2,6

1H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2University of South Florida, Tampa, FL
3Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Oncology Sciences, University of South Florida, Tampa, FL
5Department of Biostatistics, Moffitt Cancer Center, Tampa, FL
6Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Eveline de Bont, MD, PhD1*, Ardine Reedijk, MSc2*, Tim Lammens, PhD3*, Valerie de Haas, MD, PhD2*, Barbara Denys, PhD4*, Laurence Dedeken, MD5, Marry van den Heuvel, MD, PhD6*, Maroeska Loo, MD, PhD7*, Anne Uyttebroeck8*, An Vandamme, MD, PhD9*, Jutte VanderWerff-ten Bosch, MD, PhD10*, Jozsef Zsiros11*, Gertjan J.L. Kaspers, MD, PhD12 and Barbara Moerloose, MD, PhD13*

1Department of Pediatric Oncology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
2Dutch Childhood Oncology Group, Den Haag, Netherlands
3Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
4Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Gent, Belgium
5Hematology/Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium
6Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7Department of Pediatric Hematology-Oncology, Radboud University Medical Center, Nijmegen, Netherlands
8Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium
9Department of Pediatrics, University Hospital Saint-Luc, Brussel, Belgium
10Department of Pediatrics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussel, Belgium
11Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, Netherlands
12Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
13Department of Pediatric Oncology, Ghent University Hospital, Gent, Belgium

Surbhi Sidana, MD1, Paul Elson, PhD2*, Aaron T. Gerds, MD, MS3, Hetty E. Carraway, MD, MBA3, Anjali S. Advani, MD3, Yogen Saunthararajah, M.D.3, Jaroslaw P. Maciejewski, MD, Ph.D.4, Matt Kalaycio, MD3, Mikkael A. Sekeres, MD, MS3 and Sudipto Mukherjee, MD, PhD3

1Department of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN
2Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
3Leukemia Program, Cleveland Clinic, Cleveland, OH
4Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Paul B. Koller, MD1, Koji Sasaki, MD2, Farhad Ravandi, MD3, Guillermo Garcia-Manero, MD3, Susan O'Brien, MD3, Jorge E. Cortes, MD3, Tapan Kadia, MD3, Gautam Borthakur, MD3, Naveen Pemmaraju, MD3, Naval Daver, MD3, Jad Chahoud, MD4, Allison Pike, RN5*, Mark Brandt, BS6*, Sherry Pierce, BSN, BA3*, Hagop M. Kantarjian, MD3 and Elias Jabbour3

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas Hosuton Health Science Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Yue Gao, PhD1*, Bin Fan, PhD2*, Kha Le, PhD2*, Erika Manyak, BASc2*, Hua Yang, PhD2*, Katherine Yen, PhD2*, Sam Agresta, MD2, Eyal C. Attar, MD2, Jian Chen, PhD1*, Qiang Xu, PhD1*, Alessandra Tosolini, BS1*, Jay M. Mei, MD, PhD1, Anjan Thakurta1*, Robert D. Knight, MD1 and Yan Li, PhD1*

1Celgene Corporation, Summit, NJ
2Agios Pharmaceuticals, Cambridge, MA

Tara L. Lin, MD1, Laura F. Newell, MD2, Robert K. Stuart, MD3, Laura C. Michaelis, MD4, Stephen E. Rubenstein, MD5, Helen S. Pentikis, Ph.D6*, Timothy Callahan, Ph.D7*, Donna Alvarez8*, Lawrence D. Mayer, PhD8* and Arthur C. Louie, MD8

1University of Kansas Medical Center, Kansas City, KS
2Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR
3Medical University of South Carolina, Charleston, SC
4Medical College of Wisconsin, Milwaukee, WI
5St. Francis Medical Group, Indianapolis, IN
6SAJE Consulting, Baltimore, MD
7Biomedical Systems, St. Louis, MO
8Celator Pharmaceuticals, Inc., Ewing, NJ

Marta Pratcorona1*, Jordi Lopez-Pardo, MD1*, Ana Garrido, MD1*, Salut Brunet, MD, PhD1*, Josep-Maria Ribera, MD, PhD2, Mar Tormo, MD, PhD3, Lourdes Escoda, MD, PhD4*, Olga Salamero5*, Montserrat Arnan, MD, PhD6*, David Gallardo, MD7*, Joan Bargay, MD8*, Montserrat Hoyos, phD1*, Marina Diaz-Beya, MD, PhD9*, Ruth M Risueño10*, Josep F. Nomdedeu, MD, PhD1*, Jorge Sierra, MD, PhD1* and Jordi Esteve, MD, PhD11

1Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
2ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain
3Hospital Clínico Universitario de Valencia, Valencia, Spain
4ICO-Hospital Joan XXIII, Tarragona, Spain
5Hospital Universitari Vall d'Hebron, Barcelona, Spain
6Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
7Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain
8Department of Hematology. Hospital Son Llatzer, Palma de Mallorca, Spain
9Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
10Institut de recerca contra la leucèmia Josep Carreras, Barcelona, Spain
11Hematology Department, Hospital Clínic, IDIBAPS, Institut Josep Carreras, Barcelona, Spain

Shaun Fleming, MBBS (Hons), FRACP, FRCPA1*, Doen Ming Ong, MBBS1*, Kathryn Jackson, MBBS, FRACP, FRCPA2*, Sharon Avery, MBBS (Hons), FRACP, FRCPA1, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA3, Paula Marlton, MBBS, FRACP, FRCPA4, Glen A Kennedy, MBBS, FRACP, FRCPA5* and Andrew Wei, MBBS, FRACP, FRCPA, PhD6,7

1Department of Haematology, Alfred Hospital, Melbourne, Australia
2Department of Haematology, Nambour General Hospital, Nambour, Australia
3Princess Alexandra Hospital, Brisbane, Australia
4Australasian Leukaemia and Lymphoma Group Tissue Bank, Princess Alexandra Hospital, Brisbane, Australia
5Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
6Department of Haematology, The Alfred Hospital, Melbourne, Australia
7Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Cristina Papayannidis, MD, PhD1, Anna Candoni, MD2*, Michele Malagola3, Giovanni Marconi, MD1*, Marco Manfrini, PhD1*, Giorgia Simonetti, PhD1*, Elisa Zuffa, PhD1*, Maria Chiara Abbenante, MD1*, Sarah Parisi, M.D.1*, Stefania Paolini1*, Chiara Sartor1*, Eugenia Franchini1*, Emanuela Ottaviani1*, Claudia Venturi, PhD1*, Maria Chiara Fontana1*, Antonella Padella1*, Viviana Guadagnuolo, PhD4*, Maria Teresa Bochicchio1*, Anna Ferrari, PhD1*, Simona Soverini1, Nicoletta Testoni1*, Carmen Baldazzi, PhD1*, Renato Fanin2, Domenico Russo3, Michele Cavo, MD1* and Giovanni Martinelli, MD, PhD1

1Bologna University School of Medicine, Bologna, Italy
2Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
3Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation , University of Brescia, Brescia, Italy
4"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Marta Pratcorona1*, Ana Garrido, MD1*, Salut Brunet, MD, PhD1*, Jordi Esteve, MD, PhD2, María Camino Estivill, PhD1*, M. Paz Queipo De Llano, MD3*, Susana Vives4*, Montserrat Arnan, MD, PhD5*, David Gallardo, MD6*, Mar Tormo, MD, PhD7, Antoni Garcia-Guiñon, MD8*, Antonia Sampol, MD, PhD9*, Olga Salamero10*, Josep Ma Martí, MD11*, Joan Bargay, MD, PhD12*, M Carmen Pedro, MD13*, Montserrat Hoyos, phD1*, Marina Diaz-Beya, MD, PhD14*, Lourdes Escoda, MD, PhD15*, Ramon Guàrdia, MD, PhD16*, Josep Ribera, MD, PhD17, Jorge Sierra, MD, PhD1* and Josep F. Nomdedeu, MD, PhD1*

1Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
2Hematology Department, Hospital Clínic, IDIBAPS, Institut Josep Carreras, Barcelona, Spain
3Department of Hematology, Hospital Virgen de la Victoria,, Malaga, Spain
4Hospital Universitari Germans Trias i Pujol, Badalona, Spain
5Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
6Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain
7Hospital Clínico Universitario de Valencia, Valencia, Spain
8Hematology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain
9Hospital Son Espases, Palma de Mallorca, Spain
10Hospital Universitari Vall d'Hebron, Barcelona, Spain
11Hematology Department, Hospital Mútua de Terrassa, Barcelona, Spain
12Hospital Son Llàtzer, Palma de Mallorca, Spain
13Hematology Department, Hospital del Mar, Barcelona, Spain
14Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
15ICO-Hospital Joan XXIII, Tarragona, Spain
16ICO- Hospital Josep Trueta, Girona, Spain
17Department of Hematology, ICO Badalona-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autonoma de Barcelona, Badalona, Spain

Lisa Pleyer, MD, DI1*, Sonja Burgstaller, MD2*, Reinhard Stauder, MD, MSc3*, Michael Girschikofsky, MD4*, Heinz Sill, MD5, Konstantin Schlick, MD1*, Josef Thaler, MD2*, Britta Halter, MSc3*, Sigrid Machherndl-Spandl, MD4, Armin Zebisch, MD5*, Angelika Pichler, MD6*, Michael Pfeilstöcker, MD7, Eva-Maria Autzinger, MD8*, Alois Lang, MD9*, Klaus Geissler, MD10*, Daniela Voskova, MD11*, Dietmar Geissler, MD12*, Wolfgang R Sperr, MD13*, Sabine Hojas, MD14*, Inga Mandac Rogulj, MD15*, Johannes Andel, MD16* and Richard Greil, MD1

13rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria
2Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria
3Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
4Department of Hematology and Oncology, Elisabethinen Hospital, Linz, Austria
5Department of Hematology, Medical University of Graz, Graz, Austria
6Department for Hematology and Oncology, LKH Leoben, Leoben, Austria
73rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
8First Medical Department, Center for Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria
9Department of Internal Medicine, LKH Feldkirch, Feldkirch, Austria
105th Medical Department, Hospital Hietzing, Vienna, Austria
11Department of Internal Medicine III, General Hospital, Linz, Austria
121. Medical department, Klinikum Klagenfurt, Klagenfurt, Austria
13Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
14Department of Internal Medicine, LKH Fürstenfeld, Fürstenfeld, Austria
15Department of Hematology, Clinical Hospital Merkur, Zagreb, Croatia
16Department of Internal Medicine II, LKH Steyr, Steyr, Austria

Hiroshi Moritake, MD, PhD1, Shiro Tanaka, PhD2*, Hideki Nakayama, MD, PhD3*, Takako Miyamura, MD, PhD4*, Shotaro Iwamoto, MD, PhD5*, Akira Shimada, MD, PhD6, Kiminori Terui, MD, PhD7*, Akiko M. Saito8*, Norio Shiba, MD, PhD9*, Yasuhide Hayashi, MD, PhD10, Daisuke Tomizawa, MD, PhD11, Takashi Taga, MD, PhD12*, Hiroaki Goto, MD, PhD13*, Atsushi Manabe, MD, PhD14, Keizo Horibe, MD, PhD8, Shuki Mizutani, MD, PhD15* and Souichi Adachi, MD, PhD16

1Division of Pediatrics, University of Miyazaki, Miyazaki, Japan
2Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan
3Department of Pediatrics, National Hospital Organization, Fukuoka-Higashi Medical Center, Koga, Japan
4Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
5Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
6Pediatrics/Pediatric Hematology & Oncology, Okayama University Hospital, Okayama, Japan
7Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
8Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
9Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
10Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
11Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
12Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
13Division of Hemato-oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan
14Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
15Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Japan
16Department of Human Health Sciences, Kyoto University, Kyoto, Japan

Dietger Niederwieser, MD1, Verena Sophia Hoffmann, Dr.2*, Utz Krug, MD3, Rainer Krahl, Ph.D4*, Christina Sauerland, Dipl.-Math5*, Karsten Spiekermann, MD6, Stefan K. Bohlander, MD7*, Ute Hegenbart, MD8*, Wolfram Poenisch, MD1*, Vladan Vucinic, MD1*, Michael Cross, PhD9*, Nadja Jaekel, MD1*, Markus Pfirrmann10*, Antje Schulze11*, Alwin Kraemer, MD12*, Georg Maschmeyer, MD13, Christian Junghanss, MD14*, Sebastian Scholl15*, Christian Jakob, MD13, Thomas Heinicke, MD16*, Detlev Haehling17*, Norma Peter, MD18*, Ute Kreibich, Prof.19*, Christoph Busemann, MD20, Haifa Kathrin Al-Ali, MD21*, Ahmet H. Elmaagacli, MD, PhD22,23*, B Opitz24*, Hans-Heinrich Wolf, MD25*, Wolfgang Hiddemann, MD26, Wolfgang E Berdel, MD27 and Thomas Buechner28*

1Hematology and Oncology, University of Leipzig, Leipzig, Germany
2Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
3Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany
4Department of Hematology and Oncology, University Hospital of Leipzig, Leipzig, Germany
5Institut für Biometrie und Klinische Forschung, University Münster, Münster, Germany
6Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany
7Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
8Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
9Division of Hematology and Clinical Oncology, University Hospital Leipzig, Leipzig, Germany
10Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
11Helios Klinikum, Erfurt, Germany
12Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
13Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany
14Department of Medicine III - Hematology/Oncology/Palliative Care, University of Rostock Medical Center, Rostock, Germany
15University of Jena, Jena, Germany
16University of Magdeburg, Magdeburg, Germany
17Haema Onko Schwerin, Schwerin, Germany
18Internal Medicine, Carl-Thiem-Clinic Cottbus, Cottbus, Germany
19Klinik für Innere Medizin B, Heinrich-Braun-Krankenhaus, Zwickau, Germany
20Internal Medicine, Hem./Onc., University of Greifswald, Greifswald, Germany
21University of Leipzig, Leipzig, Germany
22Klinik Schwerin, Schwerin, Germany
23Hematology and Oncology, Hospital Schwerin, Schwerin, Germany
24St. Elisabeth Krankenhaus, Halle, Germany
25Department of Hematology and Oncology, University Hospital, Halle, Germany
26Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
27Department of Medicine A, University Hospital Münster, Muenster, Germany
28Department of Hematology/Oncology, University of Muenster, Muenster, Germany

Andrew Hantel, MD1*, Niloufer Khan, MD2, Richard A. Larson, MD3, Lucy A. Godley, MD, PhD4, Michael J. Thirman, MD3, Andrew Artz, MD, MS3, Olatoyosi Odenike, MD3, Hongtao Liu, MD, PhD3, Jane E. Churpek, MD4, Darren King, MD1*, Elizabeth Rich, MD4*, Kwang Jin Choi, MD4*, Randall W. Knoebel, PharmD, BCOP5* and Wendy Stock, MD3

1Department of Medicine, The University of Chicago Medicine, Chicago, IL
2Departments of Medicine and Pediatrics, The University of Chicago Medicine, Chicago, IL
3University of Chicago Medical Center, Chicago, IL
4Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL
5Department of Pharmacy, The University of Chicago Medicine, Chicago, IL

Shuning Wei1*, Siping Wang1*, Shaowei Qiu2*, Junyuan QI1*, Yingchang Mi, MD, PhD3, Dong Lin, MD, PhD3*, Chunlin Zhou, MD, PhD4*, Bingcheng Liu, MD2*, Ying Wang, MD5*, Min Wang, MD, PhD2* and Jianxiang Wang, MD, PhD6

1Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Chinese Academy of Medical Sciences & Peking Union Medical College,Hospital of Blood Diseases, Tianjin, China
5State KeInstitute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
6Institute of Hematology, Hospital of Blood Diseases, CAMS, Tianjin, China

Pierre Peterlin, MD1*, Thierry Guillaume, MD, PhD1*, Jacques Delaunay, MD1*, Mohamad Mohty, MD, PhD2, Alice Garnier, MD1*, Fanny Rialland, MD3*, Marion Strullu, MD3*, Beatrice Mahe, MD1*, Viviane Dubruille, MD1*, Nicolas Blin, MD1*, Maud Voldoire, MD1*, Cyrille Touzeau, MD, PHD1*, Thomas Gastinne, MD1*, Steven Le Gouill, MD, PhD1*, Philippe Moreau1* and Patrice Chevallier, MD, PhD1*

1Department of Hematology, Nantes University Hospital, Nantes, France
2Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France
3Department of Pediatric Hematology, Nantes University Hospital, Nantes, France

Aditi Vedi, MBBS1,2*, Richard Mitchell, MBBS FRACP2*, Cecelia Oswald3*, Glenn M Marshall, MBBS, MD, FRACP4, Toby Trahair, MBBS FRACP3* and David S. Ziegler, MBBS, FRACP, MD2

1Department of Women and Children's Health, University of New South Wales, Sydney, Australia
2Sydney Children's Hospital, Sydney, Australia
3Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia
4Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia

Catherine C. Coombs, MD1, Sean Devlin, PhD2*, Shweta Dixit, BA3*, Abhinita Mohanty4*, Kristina Marie Knapp5*, Maria Arcila, MD6*, Virginia M. Klimek, MD1, Martin S Tallman, MD1, Ross L. Levine, MD7, Raajit K. Rampal, M.D., Ph.D.8 and Franck Rapaport, PhD9*

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
4Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
5Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York
6Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
7Memorial Sloan Kettering Cancer Center, New York, NY
8Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
9Leukemia Center, Memorial Sloan Kettering Cancer Center, New York City, NY

*signifies non-member of ASH